Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 471 participants.
Also called NCT03011450
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 471 participants
- Registry
-
NCT03011450
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belarus, Bulgaria, Czechia, Georgia, Hungary, Poland, Russia, Ukraine
- Registry status
- Completed
Technical summary
Registry record NCT03011450. Randomized; triple masking; primary purpose treatment. Start 2016-11-26 (actual); primary completion 2019-07-05 (actual). Results posted on 2022-10-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
- Condition
- Severe Hypertriglyceridemia
- Intervention (Drug)
- K-877
- Intervention (Drug)
- Fenofibrate
- Intervention (Drug)
- Placebo (for K-877)
- Lead sponsor
- Kowa Research Institute, Inc.
Record details
- Record id
cardio:ct-nct03011450- Content hash
1698b330b90f81bdd3418560e3330827790a98da749e0e66cfa5ecd97fcaff76